Adaptam Therapeutics
Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.
About
Technology stack
detected 2026-06-16No comments yet. Be the first to share your take.
What does Adaptam Therapeutics do?
Adaptam Therapeutics is a biotechnology startup focused on discovering and developing new medicines for patients with rare genetic diseases. Their approach leverages cutting-edge protein degradation technologies to target the underlying causes of these conditions. The company aims to bring innovative therapies to market for previously untreatable diseases.
How much funding has Adaptam Therapeutics raised?
Adaptam Therapeutics has raised a total of $5M in funding. The most recent round on record is Seed.
Where is Adaptam Therapeutics headquartered?
Adaptam Therapeutics is headquartered in Cambridge, United States.
When was Adaptam Therapeutics founded?
Adaptam Therapeutics was founded in 2021.
What industry does Adaptam Therapeutics operate in?
Adaptam Therapeutics operates in Biotech, Drug Discovery, Genomics, Rare Diseases, Protein Degradation, Therapeutics.
How many employees does Adaptam Therapeutics have?
Adaptam Therapeutics has approximately 6 people on record.